REQUEST A DEMO
AMP Webpage  (1)

Clinical Decision Support-based Reporting: The Power of a Comprehensive Curated Knowledgebase.

As NGS assays become larger and more complex, it becomes increasingly critical for laboratories to have sufficient clinical decision support to ensure they are reporting accurate and high-quality data to their patient populations.

Join us as we will discuss CGW Plus, our reimagined NGS workflow and reporting platform, and how it utilizes our state-of-the-art Knowledgebase to enable laboratories to engage in the practice of medicine and assemble clinical content for each patient regardless of whether they are running an LDT or an IVD assay.

 

Key takeaways from this webinar will be:

  • Explore what our Knowledgebase has to offer, including everything from relevant therapies, clinical trials, literature, and databases.
  • Learn how we maintain the highest level of quality in our Knowledgebase that enabled us to power tumor profiling in Illumina’s TSO Comp assay that was recently granted FDA-approval.
  • Hear about the limitations of IVD-grade reports and how supplemental clinical decision support can help.
  • Explore how CGW Plus utilizes our best-in-class Knowledgebase to simplify and increase transparency of clinical decisions for laboratories.

Meet the speaker:

Erin is the Vice President of our Diagnostic product line, which includes responsibility for our CGW products. She has worked at Velsera, previously Pierian, since 2017 and has held a variety of leadership roles in product, professional services, and customer success. Before joining Pierian, Erin spent 6 years working at the University of Alabama – Birmingham Medical Genomics Laboratory and received her MBA from the same university in 2016. At the Medical Genomics Laboratory, which specializes in inherited disease testing for neurofibromatosis and related conditions, she performed laboratory benchwork, oversaw quality management, acted as laboratory general supervisor, and participated in clinical validations, including the laboratory’s first NGS assay in 2014.

Julie and Rakesh (4)

Erin Buck

Vice President, Product Diagnostics